Five major cardiovascular devices approved by the FDA so far in 2020
The Covid-19 pandemic may have had an overwhelming impact on the types of medical devices gaining FDA approval in 2020, but several innovations in the cardiovascular space have
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XThe Covid-19 pandemic may have had an overwhelming impact on the types of medical devices gaining FDA approval in 2020, but several innovations in the cardiovascular space have
From diagnostic procedures to minimally-invasive surgeries, miniature cameras have a multitude of uses in the medical sector. ScoutCam currently makes the world’s smallest single-use camera — a device
A new digital method for diagnosing autism in children may be set for FDA clearance after demonstrating “unparalleled accuracy” in a real-world study. Cognoa — a California-based paediatric
A novel 3D printing material from Nanoscribe opens up “new possibilities” when designing lenses for micro-optic devices. German nanotechnology firm Nanoscribe has introduced its photoresist IP-n162 – a
US shipments of Covid-19 molecular diagnostic tests have surpassed 150 million, according to medtech trade association AdvaMed. A further 100 million antigen-based tests, which are used to detect
Throughout much of 2020, 3D printing — or additive manufacturing (AM) — has been used in a variety of ways to ease the burden of Covid-19 on healthcare
The global orthopaedics market is set to decrease in value by more than 20% this year following the impact of Covid-19, according to an analyst. Analytics firm GlobalData
International trade fairs COMPAMED and MEDICA will take place entirely online this year. Having previously been set to go ahead in Düsseldorf, Germany, the events will now be
Scientists have found a way to form porous metal nanostructures in thin films. The findings could lead to improved biosensing devices in the future. Medical Device Developments writer
AstraZeneca wants to fulfil the “huge need” for better heart failure diagnosis, and is “on a mission” to reduce hospitalisations in this area, according to a company executive.